Ivan Chong Hon Kuan
Direktor/Vorstandsmitglied bei Rockeby Biomed Ltd.
Profil
Ivan Chong Hon Kuan is currently an Executive Director at Rockeby Biomed Ltd.
He previously worked as a Non-Executive Director at the same company from 2008 to 2009.
Aktive Positionen von Ivan Chong Hon Kuan
| Unternehmen | Position | Beginn |
|---|---|---|
Rockeby Biomed Ltd.
 Rockeby Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Rockeby Biomed Ltd. provides research, development and marketing of rapid testing technologies for infectious diseases in animals and humans. The company's main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments. The company is headquartered in West Perth, Australia. | Direktor/Vorstandsmitglied | 04.11.2009 |
Ehemalige bekannte Positionen von Ivan Chong Hon Kuan
| Unternehmen | Position | Ende |
|---|---|---|
Rockeby Biomed Ltd.
Rockeby Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Rockeby Biomed Ltd. provides research, development and marketing of rapid testing technologies for infectious diseases in animals and humans. The company's main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments. The company is headquartered in West Perth, Australia. | Direktor/Vorstandsmitglied | 20.04.2009 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Rockeby Biomed Ltd.
Rockeby Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Rockeby Biomed Ltd. provides research, development and marketing of rapid testing technologies for infectious diseases in animals and humans. The company's main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments. The company is headquartered in West Perth, Australia. | Commercial Services |
